West M A, Prescott A R, Eskelinen E L, Ridley A J, Watts C
Department of Biochemistry, MSI/WTB Complex, University of Dundee, Dundee, DDI 5EH, UK.
Curr Biol. 2000 Jul 13;10(14):839-48. doi: 10.1016/s0960-9822(00)00595-9.
Dendritic cells use constitutive macropinocytosis to capture exogenous antigens for presentation on MHC molecules. Upon exposure to inflammatory stimuli or bacterial products such as lipopolysaccharide (LPS), macropinocytosis is dramatically downregulated as part of a developmental programme leading to dendritic cell maturation, migration and activation of T cells. It is not known, however, how macropinocytosis is sustained in dendritic cells in the absence of exogenous stimuli, nor how it is downregulated upon maturation. We have tested the possibility that one or more members of the Rho family of GTPases are involved in and control pinocytosis in dendritic cells.
We established dendritic cell populations that show constitutive macropinocytosis that was downregulated by LPS treatment. Microinjection of immature cells with dominant-negative Rac (N17Rac1) or treatment with Clostridium difficile toxin B, the phosphoinositide 3-kinase (PI3-K) inhibitor wortmannin, or LPS all inhibited the formation of macropinosomes but, surprisingly, did not eliminate membrane ruffling. Microinjection of N17Cdc42 or the Rho inhibitor C3 transferase eliminated actin plaques/podosomes and actin cables, respectively, but had little effect on the formation of macropinosomes. Surprisingly, dendritic cells matured with LPS had equivalent or even somewhat higher levels of active Rac than immature cells. Moreover, microinjection of a constitutively active form of Rac (V12Rac1) into mature dendritic cells did not reactivate macropinocytosis.
Rac has an important role in the constitutive formation of macropinosomes in dendritic cells but may be required downstream of membrane ruffling. Furthermore, regulation of Rac activity does not appear to be the control point in the physiological downregulation of dendritic cell pinocytosis. Instead, one or more downstream effectors may be modulated to allow Rac to continue to regulate other cellular functions.
树突状细胞利用组成型巨胞饮作用摄取外源性抗原,以便在主要组织相容性复合体(MHC)分子上呈递。暴露于炎性刺激或细菌产物(如脂多糖,LPS)后,作为树突状细胞成熟、迁移及T细胞激活的发育程序的一部分,巨胞饮作用会显著下调。然而,尚不清楚在没有外源性刺激的情况下,树突状细胞中的巨胞饮作用是如何维持的,也不清楚其在成熟时是如何下调的。我们测试了Rho家族小GTP酶的一个或多个成员参与并控制树突状细胞胞饮作用的可能性。
我们建立了显示组成型巨胞饮作用的树突状细胞群体,该作用可被LPS处理下调。用显性负性Rac(N17Rac1)显微注射未成熟细胞,或用艰难梭菌毒素B、磷酸肌醇3激酶(PI3-K)抑制剂渥曼青霉素或LPS处理,均抑制了巨胞饮体的形成,但令人惊讶的是,并未消除膜皱襞。显微注射N17Cdc42或Rho抑制剂C3转移酶分别消除了肌动蛋白斑/足体和肌动蛋白束,但对巨胞饮体的形成影响不大。令人惊讶的是,用LPS成熟的树突状细胞比未成熟细胞具有同等甚至更高水平的活性Rac。此外,将组成型活性形式的Rac(V12Rac1)显微注射到成熟树突状细胞中并未重新激活巨胞饮作用。
Rac在树突状细胞中巨胞饮体的组成型形成中起重要作用,但可能在膜皱襞的下游发挥作用。此外,Rac活性的调节似乎不是树突状细胞胞饮作用生理下调的控制点。相反,可能会调节一个或多个下游效应器,以使Rac继续调节其他细胞功能。